User profiles for Arvind Dasari

N. Arvind Dasari

University of Texas MD Anderson Cancer Center
Verified email at mdanderson.org
Cited by 9971

Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States

A Dasari, C Shen, D Halperin, B Zhao, S Zhou… - JAMA …, 2017 - jamanetwork.com
Importance The incidence and prevalence of neuroendocrine tumors (NETs) are thought to
be rising, but updated epidemiologic data are lacking. Objective To explore the evolving …

[HTML][HTML] Phase II pilot study of vemurafenib in patients with metastatic BRAF-mutated colorectal cancer

…, D Maru, V Morris, F Janku, A Dasari… - Journal of clinical …, 2015 - ncbi.nlm.nih.gov
Purpose BRAF V600E mutation is seen in 5% to 8% of patients with metastatic colorectal
cancer (CRC) and is associated with poor prognosis. Vemurafenib, an oral BRAF V600 inhibitor…

[HTML][HTML] ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper

A Dasari, VK Morris, CJ Allegra, C Atreya… - Nature reviews Clinical …, 2020 - nature.com
An increasing number of studies are describing potential uses of circulating tumour DNA (ctDNA)
in the care of patients with colorectal cancer. Owing to this rapidly developing area of …

Disparity of race reporting and representation in clinical trials leading to cancer drug approvals from 2008 to 2018

JM Loree, S Anand, A Dasari, JM Unger… - JAMA …, 2019 - jamanetwork.com
Importance Representative racial/ethnic participation in research, especially in clinical trials
that establish standards of care, is necessary to minimize disparities in outcomes and to …

Epidemiology, incidence, and prevalence of neuroendocrine neoplasms: are there global differences?

S Das, A Dasari - Current oncology reports, 2021 - Springer
Purpose of Review The purpose of our review is to explore global epidemiologic trends of
gastroenteropancreatic (GEP) neuroendocrine tumors (NETs). Specifically, we sought to …

Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study

DM Halperin, C Shen, A Dasari, Y Xu, Y Chu… - The Lancet …, 2017 - thelancet.com
Background Neuroendocrine tumours (NETs) can secrete bioactive amines into the bloodstream,
causing carcinoid syndrome, with symptoms including flushing and diarrhoea. However…

Classifying colorectal cancer by tumor location rather than sidedness highlights a continuum in mutation profiles and consensus molecular subtypes

…, M Lam, AN Willauer, K Raghav, A Dasari… - Clinical Cancer …, 2018 - AACR
Purpose: Colorectal cancers are classified as right/left-sided based on whether they occur
before/after the splenic flexure, with established differences in molecular subtypes and …

[HTML][HTML] Phase I study of RO4929097, a gamma secretase inhibitor of Notch signaling, in patients with refractory metastatic or locally advanced solid tumors

…, A Patnaik, GS Falchook, A Dasari… - Journal of clinical …, 2012 - ncbi.nlm.nih.gov
… Falchook, Arvind Dasari, Geoffrey I. Shapiro, John F. Boylan, Zhi-Xin Xu, Ka Wang, Astrid
Koehler, James Song, Steven A. … Falchook, Arvind Dasari, Ka Wang, Astrid Koehler …

Oxidative stress induces premature senescence by stimulating caveolin-1 gene transcription through p38 mitogen-activated protein kinase/Sp1–mediated activation of …

A Dasari, JN Bartholomew, D Volonte, F Galbiati - Cancer research, 2006 - AACR
Cellular senescence is believed to represent a natural tumor suppressor mechanism. We
have previously shown that up-regulation of caveolin-1 was required for oxidative stress–…

Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: a SEER database analysis of 162,983 cases

A Dasari, K Mehta, LA Byers, H Sorbye, JC Yao - Cancer, 2018 - Wiley Online Library
BACKGROUND Extrapulmonary neuroendocrine carcinomas (NECs) are poorly studied and
are managed similar to lung NECs, which may not account for differences between the 2 …